Resecting the primary in unresectable stage IV colorectal cancer: Should we or shouldn't we?
- PMID: 35892253
- DOI: 10.1111/codi.16234
Resecting the primary in unresectable stage IV colorectal cancer: Should we or shouldn't we?
References
REFERENCES
-
- Loh K, Shapiro J, Tran B, Wong H, Wong S, Richardson G, et al. Tumor burden (TB) as a prognostic indicator in patients with metastatic colorectal cancer (mCRC). J Clin Oncol. 2014;32(3_Suppl):572.
-
- Osterlund P, Salminen T, Soveri L, Kallio R, Kellokumpu I, Lamminmäki A, et al. Repeated centralized multidisciplinary team assessment of resectability, clinical behavior, and outcomes in 1086 Finnish metastatic colorectal cancer patients (RAXO): a nationwide prospective intervention study. Lancet Reg Gealth Eur. 2021;3:100049.
-
- Poultsides G, Servais E, Saltz L, Patil S, Kemeny N, Guillem J, et al. Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment. J Clin Oncol. 2009;27:3379-84.
-
- Costi R, Mazzeo A, Di Mauro D, Veronesi L, Sansebastiano G, Violi V, et al. Palliative resection of colorectal cancer: does it prolong survival? Ann Surg Oncol. 2007;14(9):2567-76.
-
- Kim C, Baek J, Choi G, Yu C, Kang S, Park W, et al. The role of primary tumor resection in colorectal cancer patients with asymptomatic, synchronous unresectable metastasis: study protocol for a randomized controlled trial. Trials. 2016;17:34.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
